Literature DB >> 10411703

Predictors of adequacy of arteriovenous fistulas in hemodialysis patients.

P E Miller1, A Tolwani, C P Luscy, M H Deierhoi, R Bailey, D T Redden, M Allon.   

Abstract

BACKGROUND: Dialysis access procedures and complications represent a major cause of morbidity, hospitalization, and cost for chronic dialysis patients. To improve the outcomes of hemodialysis access procedures, recent clinical guidelines have encouraged attempts to place an arteriovenous (A-V) fistula, rather than an A-V graft, whenever possible in hemodialysis patients. There is little information, however, about the success rate of following such an aggressive strategy in the prevalent dialysis population.
METHODS: We evaluated the adequacy of all A-V fistulas placed in University of Alabama at Birmingham dialysis patients during a two-year period. A fistula was considered adequate if it supported a blood flow of >/=350 ml/min on at least six dialysis sessions in one month. Fistula adequacy was correlated with clinical and demographic factors.
RESULTS: The adequacy could be determined for 101 fistulas; only 47 fistulas (46.5%) developed sufficiently to be used for dialysis. The adequacy rate was lower in older (age >/= 65) versus younger (age < 65) patients (30.0 vs. 53.5%, P = 0.03). It was also marginally lower in diabetics versus nondiabetics (35.0 vs. 54.1%, P = 0.061) and in overweight (BMI >/= 27 kg/m2) versus nonoverweight patients (34.5 vs. 55.2%, P = 0.07). The adequacy rate was not affected by patient race, smoking status, surgeon, serum albumin, or serum parathyroid hormone. The adequacy rate was substantially lower for forearm versus upper arm fistulas (34.0 vs. 58.9%, P = 0.012). The adequacy of forearm fistulas was particularly poor in women (7%), patients age 65 or older (12%), and diabetics (21%). In contrast, upper arm fistulas were adequate in 56% of women, 54% of older patients, and 48% of diabetics.
CONCLUSIONS: An aggressive approach to the placement of fistulas in dialysis patients results in a less than 50% early adequacy rate, which is considerably lower than that reported in the past. Moreover, the success rate of fistulas is even lower for certain patient subsets. To achieve an optimal outcome with A-V fistulas, we recommend that they be constructed preferentially in the upper arm in female, diabetic, and older hemodialysis patients.

Entities:  

Mesh:

Year:  1999        PMID: 10411703     DOI: 10.1046/j.1523-1755.1999.00515.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  59 in total

1.  Improved cumulative survival in fistulas requiring surgical interventions to promote fistula maturation compared with endovascular interventions.

Authors:  Timmy Lee; Arshdeep Tindni; Prabir Roy-Chaudhury
Journal:  Semin Dial       Date:  2012-03-09       Impact factor: 3.455

Review 2.  Vascular access for dialysis in the elderly.

Authors:  P Ponce
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

3.  Comparison of radiocephalic fistulas placed in the proximal forearm and in the wrist.

Authors:  Rajeshkumar Bhalodia; Michael Allon; Alan M Hawxby; Ivan D Maya
Journal:  Semin Dial       Date:  2010-08-13       Impact factor: 3.455

4.  Outcomes of arteriovenous fistula creation after the Fistula First Initiative.

Authors:  Carrie A Schinstock; Robert C Albright; Amy W Williams; John J Dillon; Eric J Bergstralh; Bernice M Jenson; James T McCarthy; Karl A Nath
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

5.  Restoration of wall shear stress in the cephalic vein during extreme hemodynamics.

Authors:  M E Boghosian; M S Hammes; K W Cassel; S M J Akherat; F Coe
Journal:  J Med Eng Technol       Date:  2019-04-03

6.  Non-matured arteriovenous fistulae for haemodialysis: diagnosis, endovascular and surgical treatment.

Authors:  Marko Malovrh
Journal:  Bosn J Basic Med Sci       Date:  2010-04       Impact factor: 3.363

7.  Comorbidities do not influence primary fistula success in incident hemodialysis patients: a prospective study.

Authors:  Wenjie Wang; Brendan Murphy; Serdar Yilmaz; Marcello Tonelli; Jennifer Macrae; Braden J Manns
Journal:  Clin J Am Soc Nephrol       Date:  2007-11-07       Impact factor: 8.237

8.  TGFβ (Transforming Growth Factor-Beta)-Activated Kinase 1 Regulates Arteriovenous Fistula Maturation.

Authors:  Haidi Hu; Shin-Rong Lee; Hualong Bai; Jianming Guo; Takuya Hashimoto; Toshihiko Isaji; Xiangjiang Guo; Tun Wang; Katharine Wolf; Shirley Liu; Shun Ono; Bogdan Yatsula; Alan Dardik
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-05-28       Impact factor: 8.311

9.  Incidence of arteriovenous thrombosis and the role of anticardiolipin antibodies in hemodialysis patients.

Authors:  Roozbeh Jamshid; Serati Ali Reza; Ghaderi Abbas; Afshariani Raha
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

10.  Randomized controlled trial of clopidogrel to prevent primary arteriovenous fistula failure in hemodialysis patients.

Authors:  A Ghorbani; M Aalamshah; H Shahbazian; A Ehsanpour; A Aref
Journal:  Indian J Nephrol       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.